Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
DOI:
https://doi.org/10.12775/QS.2024.36.56580Keywords
physical activity, hormones, women’s health, menstrual cycle, hrt, anabolic steroidsAbstract
Introduction: Hormones influence women's health and athletic performance, managing conditions like menstrual irregularities, menopause, and osteoporosis. Therapies such as oral contraceptives and IUDs benefit millions but pose risks like breast cancer and cardiovascular events. In sports, hormonal fluctuations affect performance, with steroid abuse raising concerns. This review examines their benefits, risks, and implications.
Materials and Methods: The study conducted a systematic review of the literature, utilizing databases including PubMed, NCBI, and Google Scholar. Data were obtained from clinical and experimental studies and evaluated based on methodological rigor, participant characteristics, and therapeutic outcomes. Articles lacking full-text access were excluded from the analysis.
State of knowledge: Hormones profoundly influence women's health and athletic performance, affecting the menstrual cycle, menopause, and responses to exercise. Physical activity improves cardiovascular and metabolic health but can disrupt hormonal balance with intense training. Hormonal contraceptives, anabolic steroids, and HRT impact health and performance, necessitating individualized approaches and further research.
Conclusions: Hormonal balance is vital for women's health and performance. Physical activity, contraception, and HRT have benefits but require tailored approaches to mitigate risks.
References
Wang L, Guan HY, Xia HX, Chen XY, Zhang W. Dydrogesterone treatment for menstrual-cycle
regularization in abnormal uterine bleeding - ovulation dysfunction patients. World J Clin Cases.
;8(15):3259-3266. doi:10.12998/wjcc.v8.i15.3259
Elmaoğulları S, Aycan Z. Abnormal Uterine Bleeding in Adolescents. J Clin Res Pediatr Endocrinol.
;10(3):191-197. doi:10.4274/jcrpe.0014
Sachedina A, Todd N. Dysmenorrhea, Endometriosis and Chronic Pelvic Pain in Adolescents. J Clin
Res Pediatr Endocrinol. 2020;12(Suppl 1):7-17. doi:10.4274/jcrpe.galenos.2019.2019.S0217
Hee L, Kettner LO, Vejtorp M. Continuous use of oral contraceptives: an overview of effects and
side-effects. Acta Obstet Gynecol Scand. 2013;92(2):125-136. doi:10.1111/aogs.12036
Hodis HN, Mack WJ. Menopausal Hormone Replacement Therapy and Reduction of All-Cause
Mortality and Cardiovascular Disease: It Is About Time and Timing. Cancer J. 2022;28(3):208-223.
doi:10.1097/PPO.0000000000000591
Pkhaladze L, Russo M, Unfer V, Nordio M, Basciani S, Khomasuridze A. Treatment of lean PCOS
teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives. Eur Rev Med
Pharmacol Sci. 2021;25(23):7476-7485. doi:10.26355/eurrev_202112_27447
Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard Ø. Contemporary Hormonal
Contraception and the Risk of Breast Cancer. N Engl J Med. 2017;377(23):2228-2239.
doi:10.1056/NEJMoa1700732
Cho L, Kaunitz AM, Faubion SS, et al. Rethinking Menopausal Hormone Therapy: For Whom, What,
When, and How Long?. Circulation. 2023;147(7):597-610.
doi:10.1161/CIRCULATIONAHA.122.061559
Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral
contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev.
;2015(8):CD011054. Published 2015 Aug 27. doi:10.1002/14651858.CD011054.pub2
Huang G, Basaria S. Do anabolic-androgenic steroids have performance-enhancing effects in female
athletes?. Mol Cell Endocrinol. 2018;464:56-64. doi:10.1016/j.mce.2017.07.010
Palacios S, Colli E, Regidor PA. Multicenter, phase III trials on the contraceptive efficacy, tolerability
and safety of a new drospirenone-only pill. Acta Obstet Gynecol Scand. 2019;98(12):1549-1557.
doi:10.1111/aogs.13688
Collaborative Group On Epidemiological Studies Of Ovarian Cancer, Beral V, Gaitskell K, et al.
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52
epidemiological studies. Lancet. 2015;385(9980):1835-1842. doi:10.1016/S0140-6736(14)61687-1
Haakenstad A, Angelino O, Irvine CMS, et al. Measuring contraceptive method mix, prevalence, and
demand satisfied by age and marital status in 204 countries and territories, 1970-2019: a systematic
analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10348):295-327.
doi:10.1016/S0140-6736(22)00936-9
MacGregor KA, Gallagher IJ, Moran CN. Relationship Between Insulin Sensitivity and Menstrual
Cycle Is Modified by BMI, Fitness, and Physical Activity in NHANES. J Clin Endocrinol Metab. 2021
Sep 27;106(10):2979-2990. doi: 10.1210/clinem/dgab415. PMID: 34111293; PMCID: PMC8475204
Tűű L, Nas K, Török M, Várbíró S. SHBG Levels Do Not Correlate with Insulin Levels in PCOS with
Appropriate Fasting Insulin Sensitivity. J Clin Med. 2024 Feb 1;13(3):838. doi: 10.3390/jcm13030838.
PMID: 38337532; PMCID: PMC10856642.
Najmabadi S, Schliep KC, Simonsen SE, Porucznik CA, Egger MJ, Stanford JB. Menstrual bleeding,
cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled
analysis of three cohorts. Paediatr Perinat Epidemiol. 2020 May;34(3):318-327. doi:
1111/ppe.12644. Epub 2020 Feb 27. PMID: 32104920; PMCID: PMC8495765.
Barbu, R. Neurohormonal and pharmacological regulation of oestrogen, progesterone, luteinizing
hormone and follicle stimulating hormone over the menstrual cycle – the possible relevance of
angiontensin ii. 2021. Farmacia, 69(1), 82-89. https://doi.org/10.31925/farmacia.2021.1.11
Monaco CF, Davis JS. Mechanisms of angioregression of the corpus luteum. Front Physiol. 2023 Sep
;14:1254943. doi: 10.3389/fphys.2023.1254943. PMID: 37841308; PMCID: PMC10568036.
Huang G, Bhasin S, Pencina K, Cheng M, Jasuja R. Circulating dihydrotestosterone, testosterone, and
free testosterone levels and dihydrotestosterone-to-testosterone ratios in healthy women across the
menstrual cycle. Fertil Steril. 2022 Dec;118(6):1150-1158. doi: 10.1016/j.fertnstert.2022.09.011. Epub
Nov 9. PMID: 36371319.
Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, Kumar M. Polycystic Ovary Syndrome:
Etiology, Current Management, and Future Therapeutics. J Clin Med. 2023 Feb 11;12(4):1454. doi:
3390/jcm12041454. PMID: 36835989; PMCID: PMC9964744.
Warren M, Perlroth N. The effects of intense exercise on the female reproductive system. Journal of
Endocrinology. 2001;170(1):3-11. doi:https://doi.org/10.1677/joe.0.1700003
Haddock BL, Hopp Marshak HP, Mason JJ, Blix G. The Effect of Hormone Replacement Therapy and
Exercise on Cardiovascular Disease Risk Factors in Postmenopausal Women. Sports Medicine.
;29(1):39-49. doi:https://doi.org/10.2165/00007256-200029010-00004
Edwards ES, Sackett SC. Psychosocial Variables Related to Why Women are Less Active than Men and
Related Health Implications. Clinical Medicine Insights: Women’s Health.
;9s1(1):CMWH.S34668. doi:https://doi.org/10.4137/cmwh.s34668
Akkurt M, Ökmen MŞ, Polat M. Effects of eight-week aerobic exercises combined with resistance
training on cardiovascular risk factors in women. Biomedical Human Kinetics. 2023;15(1):1-8.
doi:https://doi.org/10.2478/bhk-2023-0001
Orio. Effects of physical exercise on the female reproductive system. Minerva endocrinologica.
;38(3). Accessed November 23, 2024. https://pubmed.ncbi.nlm.nih.gov/24126551
Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased
early insulin secretion after weight loss in obese women with polycystic ovary syndrome. The Journal
of Clinical Endocrinology & Metabolism. 1995;80(9):2586-2593.
doi:https://doi.org/10.1210/jcem.80.9.7673399
Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women
results in improvement in reproductive outcome for all forms of fertility treatment. Human
Reproduction. 1998;13(6):1502-1505. doi:https://doi.org/10.1093/humrep/13.6.1502
Skrzypulec V, Dąbrowska J, Drosdzol A. The influence of physical activity level on climacteric
symptoms in menopausal women. Climacteric. 2010;13(4):355-361.
doi:https://doi.org/10.3109/13697131003597019
Warren MP, Goodman LR. Exercise-induced endocrine pathologies. Journal of Endocrinological
Investigation. 2003;26(9):873-878. doi:https://doi.org/10.1007/bf03345238
Morino S, Hirata H, Matsumoto D, Yokota I, Aoyama T. Patterns of premenstrual syndrome in
collegiate women: A cross-sectional study. Medicine. 2022;101(35):e30186.
doi:https://doi.org/10.1097/md.0000000000030186
Siminiuc R, Ţurcanu D. Impact of nutritional diet therapy on premenstrual syndrome. Frontiers in
Nutrition. 2023;10. doi:https://doi.org/10.3389/fnut.2023.1079417
Anushka Raipure, Patil S. The Role of Benson’s and Mitchell’s Relaxation Techniques in the
Management of Premenstrual Syndrome: An In-Depth Review. Cureus. Published online August 20,
doi:https://doi.org/10.7759/cureus.43822
Zahra Molazem, Alizadeh M, Masoume Rambod. The Effect of Benson’s Relaxation Technique on Pain
Intensity, Belief, Perception, and Acceptance in adult Hemophilia Patients: A Randomized Controlled
Trial. PubMed. 2021;9(3):187-198. doi:https://doi.org/10.30476/ijcbnm.2021.87937.1471
Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA. Low-Dose Sertraline in the Treatment
of Moderate-to-Severe Premenstrual Syndrome. The Journal of Clinical Psychiatry.
;67(10):1624-1632. doi:https://doi.org/10.4088/jcp.v67n1020
Cerqueira RO, Frey BN, Leclerc E, Brietzke E. Vitex agnus castus for premenstrual syndrome and
premenstrual dysphoric disorder: a systematic review. Archives of Women’s Mental Health.
;20(6):713-719. doi:https://doi.org/10.1007/s00737-017-0791-0
Howard SA, Benhabbour SR. Non-Hormonal Contraception. J Clin Med. 2023 Jul 20;12(14):4791. doi:
3390/jcm12144791. PMID: 37510905; PMCID: PMC10381146.
Kerscher M, Reuther T, Krueger N, Buntrock H. Effects of an oral contraceptive containing
chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal
contraception. J Eur Acad Dermatol Venereol. 2013 May;27(5):601-8. doi:
1111/j.1468-3083.2012.04497.x. Epub 2012 Mar 10. PMID: 22404700.
Hofmeyr GJ, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C. Effects of depot
medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex
hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical
trial. BMC Womens Health. 2024 Mar 8;24(1):167. doi: 10.1186/s12905-024-02990-8. PMID:
; PMCID: PMC10921651.
Le Guen M, Schantz C, Régnier-Loilier A, de La Rochebrochard E. Reasons for rejecting hormonal
contraception in Western countries: A systematic review. Soc Sci Med. 2021 Sep;284:114247. doi:
1016/j.socscimed.2021.114247. Epub 2021 Jul 20. PMID: 34339927.
Han L, Park D, Reddy A, Wilmarth PA, Jensen JT. Comparing endocervical mucus proteome of humans
and rhesus macaques. Proteomics Clin Appl. 2021 Jul;15(4):e2100023. doi: 10.1002/prca.202100023.
Epub 2021 May 26. PMID: 33991406; PMCID: PMC8653767.
Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine
contraceptive devices. Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1263-9. doi:
1016/s0002-9378(99)70120-1. PMID: 10561657.
Cooper DB, Patel P. Oral Contraceptive Pills. 2024 Feb 29. In: StatPearls [Internet]. Treasure Island
(FL): StatPearls Publishing; 2024 Jan–. PMID: 28613632.
Enfield K, Cartwright M, Toit RL, Avenant C, Africander D, Hapgood JP. Characterisation of
progestins used in hormonal contraception and progesterone via the progesterone receptor. Biochem
Biophys Res Commun. 2020 Dec 17;533(4):879-885. doi: 10.1016/j.bbrc.2020.09.058. Epub 2020 Sep
PMID: 33008590; PMCID: PMC8129485.
Grandi G, Farulla A, Sileo FG, Facchinetti F. Levonorgestrel-releasing intra-uterine systems as female
contraceptives. Expert Opin Pharmacother. 2018 May;19(7):677-686. doi:
1080/14656566.2018.1462337. Epub 2018 Apr 11. PMID: 29637798.
Huvinen E, Holopainen E, Heikinheimo O. Norethisterone and its acetate - what's so special about
them? BMJ Sex Reprod Health. 2021 Apr;47(2):102-109. doi: 10.1136/bmjsrh-2020-200619. Epub
May 12. PMID: 32398290.
Rauchenzauner M, Deichmann S, Pittschieler S, Bergmann M, Prieschl M, Unterberger I, Rösing B,
Seger C, Moser C, Wildt L, Luef G. Bidirectional interaction between oral contraception and
lamotrigine in women with epilepsy - Role of progestins. Seizure. 2020 Jan;74:89-92. doi:
1016/j.seizure.2019.11.011. Epub 2019 Nov 25. PMID: 31869755.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child
Health and Human Development; 2006–. Dienogest. 2021 Nov 15. PMID: 30000815.
Vercellini P, Esposito G, Santucci C, Parazzini F, La Vecchia C. Nomegestrol acetate for symptomatic
endometriosis and meningioma risk: understandable statistics for decision-making. Eur J Obstet
Gynecol Reprod Biol. 2023 Jul;286:149-150. doi: 10.1016/j.ejogrb.2023.05.002. Epub 2023 May 6.
PMID: 37183159.
Fu D, Huang J, Li K, Chen Y, He Y, Sun Y, Guo Y, Du L, Qu Q, Miao Y, Hu Z.
Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice
simulates androgenetic alopecia. Biomed Pharmacother. 2021 May;137:111247. doi:
1016/j.biopha.2021.111247. Epub 2021 Jan 29. PMID: 33517191.
Knopp RH, LaRosa JC, Burkman RT Jr. Contraception and dyslipidemia. Am J Obstet Gynecol. 1993
Jun;168(6 Pt 2):1994-2005. doi: 10.1016/s0002-9378(12)90941-2. PMID: 8512044.
Ko SH, Kim HS. Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for
Postmenopausal Women. Nutrients. 2020 Jan 13;12(1):202. doi: 10.3390/nu12010202. PMID:
; PMCID: PMC7019719.
Ng YW, Liang S, Singh K. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho
Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.
Contraception. 2009 Jan;79(1):24-8. doi: 10.1016/j.contraception.2008.07.012. Epub 2008 Sep 18.
PMID: 19041437.
Cockrum RH, Soo J, Ham SA, Cohen KS, Snow SG. Association of Progestogens and Venous
Thromboembolism Among Women of Reproductive Age. Obstet Gynecol. 2022 Sep 1;140(3):477-487.
doi: 10.1097/AOG.0000000000004896. Epub 2022 Aug 3. PMID: 35926206; PMCID: PMC9669089.
Creinin MD, Westhoff CL, Bouchard C, Chen MJ, Jensen JT, Kaunitz AM, Achilles SL, Foidart JM,
Archer DF. Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and
safety results. Contraception. 2021 Sep;104(3):222-228. doi: 10.1016/j.contraception.2021.05.002.
Epub 2021 May 15. PMID: 34000251.
Foidart JM. Added benefits of drospirenone for compliance. Climacteric. 2005 Oct;8 Suppl 3:28-34.
doi: 10.1080/13697130500330309. PMID: 16203653.
Pkhaladze L, Russo M, Unfer V, Nordio M, Basciani S, Khomasuridze A. Treatment of lean PCOS
teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives. Eur Rev Med
Pharmacol Sci. 2021 Dec;25(23):7476-7485. doi: 10.26355/eurrev_202112_27447. PMID: 34919250.
Foidart JM, Faustmann T. Advances in hormone replacement therapy: weight benefits of drospirenone,
a 17alpha-spirolactone-derived progestogen. Gynecol Endocrinol. 2007 Dec;23(12):692-9. doi:
1080/09513590701582323. PMID: 18075844.
Oxfeldt M, Dalgaard LB, Jørgensen AA, Hansen M. Hormonal Contraceptive Use, Menstrual
Dysfunctions, and Self-Reported Side Effects in Elite Athletes in Denmark. Int J Sports Physiol
Perform. 2020;15(10):1377-1384. Published 2020 Sep 21. doi:10.1123/ijspp.2019-0636
Schaumberg MA, Emmerton LM, Jenkins DG, Burton NW, Janse de Jonge XAK, Skinner TL. Use of
Oral Contraceptives to Manipulate Menstruation in Young, Physically Active Women. Int J Sports
Physiol Perform. 2018;13(1):82-87. doi:10.1123/ijspp.2016-0689
Elliott-Sale KJ, McNulty KL, Ansdell P, et al. The Effects of Oral Contraceptives on Exercise
Performance in Women: A Systematic Review and Meta-analysis. Sports Med. 2020;50(10):1785-1812.
doi:10.1007/s40279-020-01317-5
Wikström-Frisén L, Boraxbekk CJ, Henriksson-Larsén K. Effects on power, strength and lean body
mass of menstrual/oral contraceptive cycle based resistance training. J Sports Med Phys Fitness.
;57(1-2):43-52. doi:10.23736/S0022-4707.16.05848-5
Dragutinovic B, Moser F, Notbohm HL, Ihalainen JK, Bloch W, Schumann M. Influence of menstrual
cycle and oral contraceptive phases on strength performance, neuromuscular fatigue, and perceived
exertion. J Appl Physiol (1985). 2024;137(4):919-933. doi:10.1152/japplphysiol.00198.2024
Nolan D, McNulty KL, Manninen M, Egan B. The Effect of Hormonal Contraceptive Use on Skeletal
Muscle Hypertrophy, Power and Strength Adaptations to Resistance Exercise Training: A Systematic
Review and Multilevel Meta-analysis. Sports Med. 2024;54(1):105-125.
doi:10.1007/s40279-023-01911-3
Piatkowski T, Whiteside B, Robertson J, Henning A, Lau EHY, Dunn M. What is the prevalence of
anabolic-androgenic steroid use among women? A systematic review. Addiction.
;119(12):2088-2100. doi:10.1111/add.16643
Havnes IA, Jørstad ML, Innerdal I, Bjørnebekk A. Anabolic-androgenic steroid use among women - A
qualitative study on experiences of masculinizing, gonadal and sexual effects. Int J Drug Policy.
;95:102876. doi:10.1016/j.drugpo.2020.102876
Piatkowski T, Robertson J, Lamon S, Dunn M. Gendered perspectives on women's anabolic-androgenic
steroid (AAS) usage practices. Harm Reduct J. 2023;20(1):56. Published 2023 Apr 25.
doi:10.1186/s12954-023-00786-x
Kim HK, Della-Fera MA, Hausman DB, Baile CA. Effect of clenbuterol on apoptosis, adipogenesis,
and lipolysis in adipocytes. J Physiol Biochem. 2010;66(3):197-203. doi:10.1007/s13105-010-0024-8
Abrahin O, Souza NS, de Sousa EC, Santos AM, Bahrke MS. Anabolic-androgenic steroid use among
Brazilian women: an exploratory investigation. J Subst Use. 2016;22(3):246-252.
doi:10.1080/14659891.2016.1179806.
Huang G, Basaria S, Travison TG, et al. Testosterone dose-response relationships in hysterectomized
women with or without oophorectomy: effects on sexual function, body composition, muscle
performance and physical function in a randomized trial. Menopause. 2014;21(6):612-623.
doi:10.1097/GME.0000000000000093
Gruber AJ, Pope HG Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women.
Psychother Psychosom. 2000;69(1):19-26. doi:10.1159/000012362
Nieschlag E, Vorona E. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping
with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol.
;173(2):R47-R58. doi:10.1530/EJE-15-0080
Strauss RH, Liggett MT, Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained
women athletes. JAMA. 1985;253(19):2871-2873.
Peacock K, Carlson K, Ketvertis KM. Menopause. 2023 Dec 21. In: StatPearls [Internet]. Treasure
Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29939603.
Peycheva D, Sullivan A, Hardy R, Bryson A, Conti G, Ploubidis G. Risk factors for natural menopause
before the age of 45: evidence from two British population-based birth cohort studies. BMC Womens
Health. 2022 Nov 8;22(1):438. doi: 10.1186/s12905-022-02021-4. PMID: 36348338; PMCID:
PMC9644638.
Takahashi TA, Johnson KM. Menopause. Med Clin North Am. 2015 May;99(3):521-34. doi:
1016/j.mcna.2015.01.006. PMID: 25841598.
Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition.
Recent Prog Horm Res. 2002;57:257-75. doi: 10.1210/rp.57.1.257. PMID: 12017547.
Davis SR, Martinez-Garcia A, Robinson PJ, Handelsman DJ, Desai R, Wolfe R, Bell RJ; ASPREE
Investigator Group. Estrone Is a Strong Predictor of Circulating Estradiol in Women Age 70 Years and
Older. J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3348–54. doi: 10.1210/clinem/dgaa429. PMID:
; PMCID: PMC7394338.
Santoro N, Epperson CN, Mathews SB. Menopausal Symptoms and Their Management. Endocrinol
Metab Clin North Am. 2015 Sep;44(3):497-515. doi: 10.1016/j.ecl.2015.05.001. PMID: 26316239;
PMCID: PMC4890704.
El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, Limacher MC,
Manson JE, Stefanick ML, Allison MA; American Heart Association Prevention Science Committee of
the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing.
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention:
A Scientific Statement From the American Heart Association. Circulation. 2020 Dec
;142(25):e506-e532. doi: 10.1161/CIR.0000000000000912. Epub 2020 Nov 30. PMID: 33251828.
WIŚNIEWSKA, Alicja, NAPIERAŁA, Marek, PEZALA, Małgorzata and ZUKOW, Walery. The effect
of physical activity on psychomotor women menopausal. Pedagogy and Psychology of Sport. Online.
November 2015. Vol. 1, no. 1, pp. 41-58. [Accessed 24 November 2024]. DOI
12775/PPS.2015.01.01.004.
Nilsson S, Henriksson M, Hammar M, Berin E, Lawesson SS, Ward LJ, Li W, Holm AS. A 2-year
follow-up to a randomized controlled trial on resistance training in postmenopausal women: vasomotor
symptoms, quality of life and cardiovascular risk markers. BMC Womens Health. 2024 Sep
;24(1):511. doi: 10.1186/s12905-024-03351-1. PMID: 39272114; PMCID: PMC11396825.
Pertyński, Tomasz and Grzegorz Stachowiak. “A standard of oral hormone replacement therapy in
women after menopause – 1 mg of 17β-estradiol plus dydrogesterone?” (2005).
Martino, Pablo. “El rendimiento mnésico en la mujer climatérica: una revisión The memory
performance in the climacteric women: a review.” (2014).
Afaghi S, Rahimi FS, Soltani P, Kiani A, Abedini A. Sex-Specific Differences in Cardiovascular
Adaptations and Risks in Elite Athletes: Bridging the Gap in Sports Cardiology. Clin Cardiol. 2024
Sep;47(9):e70006. doi: 10.1002/clc.70006. PMID: 39228309; PMCID: PMC11372237.
Hodis HN, Mack WJ. Menopausal Hormone Replacement Therapy and Reduction of All-Cause
Mortality and Cardiovascular Disease: It Is About Time and Timing. Cancer J. 2022 May-Jun
;28(3):208-223. doi: 10.1097/PPO.0000000000000591. PMID: 35594469; PMCID: PMC9178928.
Dadgostar H, Soleimany G, Movaseghi S, Dadgostar E, Lotfian S. The effect of hormone therapy on
bone mineral density and cardiovascular factors among Iranian female athletes with
amenorrhea/oligomenorrhea: A randomized clinical trial. Med J Islam Repub Iran. 2018 Apr 1;32:27.
doi: 10.14196/mjiri.32.27. PMID: 30159278; PMCID: PMC6108246.
Rahnama, Mansur et al. “Influence of hormone replacement therapy on the level of alkaline
phosphatase and acid phosphatase in serum and saliva among women with estrogen deficiency.” (2012).
Hagmar, Magnus. “Menstrual status and long-term cardiovascular effects of intense exercise in top elite
athlete women.” (2008).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Tomasz Maciejczyk, Jakub Sadowski, Antoni Sieńko, Małgorzata Łabuś, Julia Dołęga, Piotr Mól, Bartłomiej Zabawa, Patrycja Hudzińska , Łukasz Stanisław Papież, Karol Krzykawski

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 109
Number of citations: 0